Cambrex Corp. (CBM) Tops Q3 EPS by 6c; FY16 Outlook Increased
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Cambrex Reports Third Quarter 2016 Financial Results
November 4, 2016 7:00 AM EDT- Sales increased 8% in the quarter, full year sales and profit guidance increased -
- Acquisition of North Carolina based PharmaCore completed -
- Conference call at 8:30 a.m. ET on November 4, 2016 -
EAST RUTHERFORD, N.J., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reports results for the third quarter ended September 30, 2016.
Highlights
Sales increased... More